期刊文献+

比较普萘洛尔联用硝苯吡啶与硝苯吡啶控释片对高血压病患者心率变异性的影响 被引量:1

下载PDF
导出
摘要 目的观察普萘洛尔联用硝苯吡啶治疗高血压患者对心率变异性(HRV)、血压、心率的影响是否达到硝苯吡啶控释片同样的效果。方法将51例高血压患者在停用所有降压药及对HRV有影响的药物2周后随机分为治疗组26例和对照组(硝苯吡啶控释片组)25例,分别在服药前及服药后4周做动态心电图检查,观察HRV、血压、心率并进行比较。结果两组治疗后收缩压(SBP)和舒张压(DBP)均下降,血压控制良好;两组治疗后心率稍有下降,差异无统计学意义;两组治疗后正常RR间期的标准差(SDNN)、相邻RR之差的均方根(RMSSD)、相邻RR之差〉50 m s占窦性心搏的码数(PNN50)、高频成分(HF)、低频与高频成分(LF/HF)均升高,组间比较差异无统计学意义,SDANN、LF无明显改变。结论普萘洛尔联用硝苯吡啶治疗高血压患者不激活交感神经张力,并提高迷走神经的活性,达到硝苯吡啶控释片同样的治疗效果,此方案尤其适合基层医院使用。
作者 鲁永菊 周蜜
出处 《中原医刊》 2007年第18期15-16,共2页 Central Plains Medical Journal
  • 相关文献

参考文献5

二级参考文献22

  • 1范中杰,杨静霞,吴宁.急性心肌梗塞患者尿儿茶酚胺变化及其与临床和心率变异性的关系[J].中华心血管病杂志,1997,25(2):106-108. 被引量:15
  • 2范中杰,中华内科杂志,1996年,35卷,103页
  • 3团体著者,中华心血管病杂志,1996年,24卷,183页
  • 4Pasty MB,Heckbert SR,Koepsell TD,et al.The risk of myocardial infarction associated with antihypertensive drug therapies[J].JAMA,1995,274(8):620.
  • 5Opie LH,Messererli FH.Nifedipine and mortality[J].1995,92:1068.
  • 6Lin JL,Chan HL,Du CC,et al.Long-term beta-blocker therapy improves autonomic nervous regulation in advanced congestive heart failure:A longitudinal heart rate variability study[J].Am Heart J,1999,137(4 pt 1):658.
  • 7Aldeman NH,Cohern H,Rogue R,et al.Effect of long-acting calcium antagonists on cardiovascular outcomes in hypertensive patients[J].Lancet,1997,349:594.
  • 8Fauchier L,Babuty D,Fauchier JP.Heart rate variability and prognosis in coronary artery disease[J].Eur Heart J,1999,20(15):1135.
  • 9Kleiger RE,Miller ZP,Bigger JT,et al.Decreased heart rate variability and its association with increased mortality after acute myocardial infarction[J].Am J cardiol,1987,59(3):256.
  • 10Poole-Wilson PA,Luben J,Kirwan BA,et al.Effect of long-acting nifedipine on mortality and cardiovascular morbidity in patients with stable angina requiring treatment(ACTION trial):Randomized controlled trial[J].Lancet,2004,364(9437):849.

共引文献16

同被引文献29

  • 1Benjamin EJ, Levy D, Vaziri SM, et al. Independent risk factors for atrial? brillation in a population -based cohort [J]. Framingham Heart Study, 1994,271 : 840-844.
  • 2Starnbler BS, Ellenbogen KA, Orav EJ , et al. Predictors and clinical impact of atrial? brillation after pacemaker implantation in elderly patients treated with dual chamber versus ventricular pacing [J]. Pacing Clin Electrophysiol, 2003 ,26: 2000-2007.
  • 3Svedjeholm R, Hakanson E, Predictors of atrial. brillation in patients undergoing surgery for ischemic heart disease[J]. Scand Cardiovasc J ,2000,34:516-521.
  • 4NATALIE A,SANDERS DO,et al. Restoring sinus rhythm results in biood preesure reduction in Patients With persistent Atial Fibrillation and a history of hypertension [J]. J Cardiovasc Electrophysiol , 23 ,722-726.
  • 5David D1 , Guize L, Leheuzey JY , et al. Electrophysiologic effects of intravenous nicardipine on sinus node function and conduction in humans[J]. J Cardiovasc Phannacol, 1990, 15(1): 130-7.
  • 6von Leitner ER, Biamino G. Clinical electrophysiological properties of penbutolol . a non-selective beta-blocking agent[J]. Eur J Cardi- 01,1980,12(2): 121-128.
  • 7Materson Bll , Reda DJ, Williams DW. Comparison of effects of antihypertensive drugs on heart rate: changes from baseline by baseline group and over time. Department of Veterans Affairs Cooperative Study Group on Antihypertensive Agentsjf] , Am J Hypertens- 1998,11(5) :597-601.
  • 8Michel Azizi, Anne Blanchard. Effect of contrasted sodium diets on the pharmacokinetics and pharmacodynamic effects of renin? Angiotensin System Blockers[J]. Hypertension, 2013 ,61: 1239-1245.
  • 9Yamashita T1 , Inoue H. Heart rate-reducing effects of bisoprolol in Japanese patients with chronic atrial fibrillation: results of the MAIN-AF study[J]. Journal of cardiology ,2013, 62:50-57.
  • 10Jan A, Heart rate variability on antihypertensive drugs in Black patiens in sub-sabaran Mrica[J]. Blood Pressure, 2013 , 1-7,.

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部